Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer.
Hashemi-Sadraei, Nooshin
Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2016 - e277-82 p. digital
Publication Type: Journal Article; Review
1548-8756
10.14694/EDBK_157801 doi
Antibodies, Monoclonal--therapeutic use
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Cycle Checkpoints--drug effects
Head and Neck Neoplasms--drug therapy
Humans
Immunotherapy
Neoplasm Metastasis
Neoplasm Recurrence, Local--drug therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
T-Lymphocytes--drug effects
Immunotherapy and Checkpoint Inhibitors in Recurrent and Metastatic Head and Neck Cancer. [electronic resource] - American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting 2016 - e277-82 p. digital
Publication Type: Journal Article; Review
1548-8756
10.14694/EDBK_157801 doi
Antibodies, Monoclonal--therapeutic use
B7-H1 Antigen--antagonists & inhibitors
CTLA-4 Antigen--antagonists & inhibitors
Cell Cycle Checkpoints--drug effects
Head and Neck Neoplasms--drug therapy
Humans
Immunotherapy
Neoplasm Metastasis
Neoplasm Recurrence, Local--drug therapy
Programmed Cell Death 1 Receptor--antagonists & inhibitors
T-Lymphocytes--drug effects